Life Science
UW Medicine’s Institute for Protein Design Leases 32,000 SQFT at 330 Yale in Seattle
The new lease is the first major life sciences lease in Seattle this year Seattle – April 7, 2024 – CBRE announced it...
Seattle Life Sciences Market Poised for Growth Amidst Rising Investment and Development
Seattle's life sciences sector continues to expand, driven by strong venture capital investment, strategic acquisitions and steady employment growth, according to a recently...
Lincoln Property, Intercontinental Real Estate Announce Participants in CoLabs Incubator Program at 222 Fifth in Seattle
222 Fifth Welcomes Biotech Innovators to its CoLabs Incubator ProgramSEATTLE – Lincoln Property Company (“Lincoln”), a global full-service real estate firm, and Intercontinental...
Seattle’s Life Sciences Market Update: New Leases, VC Funding, and Developments
Seattle’s life sciences sector remains one of the most dynamic components of the city’s economy, even as overall investment levels adjust from the...
200,000 SQFT 222 Fifth Building in Seattle Showcases Modern Workplace Made for R&D Innovation
Seattle, WA—Located adjacent to the iconic Seattle Center, 222 Fifth is a 9-story, 200,000-square-foot, cutting-edge research and development (R&D) building that prioritizes flexibility,...
SNBL & Plug and Play Launch Dual Innovation Hubs in Everett and Seattle, Anchoring U.S.-Japan Life Sciences Collaboration
Shin Nippon Biomedical Laboratories (SNBL) has unveiled its vision to establish the Pacific Northwest as a global leader in life sciences and technology...
Alexandria Real Estate Equities Plans $280MM Addition to South Lake Union Campus in Seattle
By The Registry Staff A major development firm is continuing its significant investment in Seattle's South Lake Union neighborhood with a new $280...
KKR’s 330 Yale in Seattle Bets on Speculative Lab Space to Fill Vacant Space
The owner of 330 Yale, a nine-story, 211,000-square-foot life science building in Seattle, is investing heavily to attract tenants amidst a challenging market....
Gilead Sciences to Close Seattle Office, Lay Off 72 Employees Located at Alexandria’s 199 E. Blaine Property
Gilead Sciences Inc., the global biopharmaceutical company renowned for its HIV treatments, is set to close its Seattle office. As outlined in a...
Seattle City Council Approves Three-Year Modification for Design Review Process
By Kate Snyder Seattle’s design review process will see a more streamlined process for certain projects in the future. During a meeting on...
Fed’s 50-Point Rate Cut: What It Means for Real Estate Investors and Consumers
Federal Open Market Committee Kicks Off Rate Reduction Cycle In a highly anticipated move, the Federal Open Market Committee (FOMC) slashed the federal...
Alexandria Real Estate Equities Sells 100,000 SQFT Life Science Property in Seattle to Fred Hutch for $150MM
PASADENA, Calif., Sept. 12, 2024 -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer...
